About BACBV
BACBV is a Healthcare company based in Naarden (Netherlands) founded in 2002, and was acquired by Life Technologies in January 2013. Discovers, develops and manufactures separation and affinity purification products. BACBV has raised $2.19 million across 3 funding rounds from investors including Life Technologies, Unilever Ventures and Fleming Family & Partners. Its chief executive, as recorded, is Amar Patel. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Affinity Resins.
Company details
Founded in 2002 in Naarden, Netherlands, BAC focuses on the biopharmaceutical sector. Separation and affinity purification products are discovered, developed, and manufactured using proprietary single-chain antibody technology known as CaptureSelect. These products support discovery, preclinical, and clinical stages in therapeutic protein production, including antibodies and fragments. Integration into Life Technologies Corporation occurred in January 2013.
- Headquarters Naarden, Netherlands
- Stage Acquired
- SectorsHealthcare
- Website bacbv.com
- Social LinkedIn
- Acquired by Life Technologies (Jan 2013)
- Total Equity Funding$2.19M (USD)
in 3 rounds
- Latest Funding Round$2.19M (USD), Series A
Sep 2008
- InvestorsLife Technologies
& 2 more
- Acquired byLife Technologies
(Jan 2013)
Funding Insights of BACBV
BACBV has successfully raised a total of $2.19M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.19 million completed in September 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.19M
- Total Rounds 3
- Last Round Series A — $2.19M
- Investors Count 2
All 3 funding rounds of BACBV with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2008 | $2.19M | Series A | – | – | |
| Jun 2005 | Series A | – | – | ||
| Jun 2002 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in BACBV
BACBV has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Life Technologies, Unilever Ventures and Fleming Family & Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital firm focused on consumer tech and multiple sectors | unileverventures.com | London, United Kingdom | ||
| ffandp.com | ||||
Tools and technologies for biotech and biopharma research were supplied. | 1983 | lifetechnologies.com | Carlsbad, United States |
Investor details for BACBV
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BACBV
1 people are tracked at BACBV (1 in leadership).
| Name | Role | Group |
|---|---|---|
Amar Patel | CEO & President | Leadership |
Complete people profiles for BACBV
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BACBV
4 dated milestones of BACBV across 11 years, from founding to its latest funding, stage changes and deals.
- Founded BACBV is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $2.2M.
- Exit Acquired by Life Technologies.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bacbv
Complete news archive for BACBV
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BACBV
BACBV was founded in 2002.
BACBV is headquartered in Naarden, Netherlands. It is registered at Naarden, North Holland, Netherlands.
Amar Patel is the CEO of BACBV, as recorded in our data.
BACBV is a funded company, having raised a total of $2.19M across 3 funding rounds to date.
Founded in 2002 in Naarden, Netherlands, BAC focuses on the biopharmaceutical sector. Separation and affinity purification products are discovered, developed, and manufactured using proprietary single-chain antibody technology known as CaptureSelect. These products support discovery, preclinical, and clinical stages in therapeutic protein production, including antibodies and fragments. Integration into Life Technologies Corporation occurred in January 2013.
BACBV has 3 investors. Key investors include Life Technologies, Unilever Ventures, and Fleming Family & Partners.
Yes. BACBV was acquired by Life Technologies in January 2013.